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Abstract: An antiviral drug for treatment of dengue is an urgent necessity. In this study in silico activities of essential oils components on 
dengue virus (DENV) were evaluated, and β-Caryophyllene was subjected to biological examination to assess inhibition of DENV-2 
replication. Components previously optimized were coupled with viral proteins prepared, using AutoDock Vina. Theoretical affinity values 
varied between -4.0 and -7.3 kcal/mol. α-copaene, β-bourbonene, germacrene D, spathulenol, β-caryophyllene, caryophyllene oxide and (+)-
epi-bicyclosesquiphellandrene showed the greatest interaction with viral proteins. β-caryophyllene inhibits DENV-2 in vitro (50% inhibitory 
concentration [IC50] = 22.5 ± 5.6 µM [4.6 ± 1.1 µg/mL] and resulted non-cytostatic with a selectivity index value of 71.1. The in silico 
results permit infer that DENV proteins are potential targets for the concomitant docking of various essential oils components. Biological 
examination suggest that β-caryophyllene acts on very early steps of the viral replication cycle and it might prove virucidal. 
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Resumen: Una droga antiviral para tratamiento del dengue es una necesidad urgente. En este estudio se evaluó la actividad in silico de 
componentes de aceites esenciales sobre el virus del dengue (VDEN) y el β-cariofileno se seleccionó para evaluar la inhibición sobre la 
replicación in vitro del VDEN-2. Los componentes previamente optimizados fueron acoplados con proteínas virales preparadas, utilizando 
AutoDock Vina. Los valores de afinidad variaron entre -4.0 and -7.3 kcal/mol. α-Copaeno, β-bourboneno, germacreno D, spatulenol, β-
cariofileno, óxido de cariofileno y (+)-epi-biciclosesquifellandreno presentaron la mayor interacción con las proteínas virales. β-Cariofileno 
inhibió VDEN-2 in vitro (Concentración inhibitoria 50 [IC50] = 22.5 ± 5.6 µM [4.6 ± 1.1 µg/mL] y resultó no-citostático con índice de 
selectividad de 71.1. Los resultados in silico indican que proteínas del VDEN son blancos potenciales para varios componentes. El análisis 
biológico sugiere que el β-cariofileno actúa en etapas tempranas de la replicación viral y podría ser virucida. 
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INTRODUCTION 
Dengue viral infection has become an increasing 
global health concern with over two-fifths of the 
world's population at risk of infection. Dengue virus 
(DENV) is a vector-borne virus, transmitted to 
humans via infected Aedes mosquitoes in tropical and 
sub-tropical areas (Murrell et al., 2011). There are 
four antigenically distinct, closely related serotypes 
of the dengue virus (DENV1–4), exhibiting a 65–
70% sequence homology (Noble et al., 2010).The 
DENV genome is comprised of approximately 10.7  
kilobases (kb) of single stranded RNA of positive 
polarity (Rossi et al., 2012). This RNA encodes three 
structural proteins (C, prM and E) that form the 
components of the virion, and seven nonstructural 
proteins (NS1, NS2A/B, NS3, NS4A/B, NS5) (Perera 
& Kuhn, 2008; Herrero et al., 2013), (Figure 1). The 
DENV capsid (C) is a small, positively charged 
protein containing membrane-associated alpha-
helical structures that form the inner core of the 
virion (Ma et al, 2004; Rossi et al., 2012). 
 
 
 
 
Figure 1 
Dengue Virus proteins 
 
The prM protein is the immature precursor to 
the membrane (M) protein found in the virions. It 
forms a scaffold over the viral envelope (E) protein to 
prevent premature fusion during virion maturation 
(Perera & Kuhn, 2008; Rossi et al., 2012). The E 
protein comprises the majority of the surface area on 
the mature virion and is responsible for receptor 
binding and host cell surface fusion (Stevens et al., 
2009; Rossi et al., 2012). The functions of NS1 are 
not completely known. Like the E protein, NS1 
contains 12 disulfide bridge-forming cysteine 
residues and encodes N-linked glycosylation sites at 
N130 and N207 (Rossi et al., 2012). NS2A is a small, 
hydrophobic protein that in several flaviviruses plays 
a role in modulating the type I interferon (IFN) 
response (Rossi et al., 2012). NS2B is another small, 
hydrophobic protein that acts as a cofactor for the 
enzymatic activity of NS3. NS3, along with NS2B, 
has multiple functions including protease and 
helicase (Sampath & Padmanabhan, 2009; Rossi et 
al., 2012). NS4A and NS4B are small, 
multifunctional, hydrophobic proteins that have 
recently been shown to play a role in modulating the 
host type I IFN responses (Rossi et al., 2012). NS5 
acts as the RNA-dependent RNA-polymerase (RdRp) 
and is responsible for RNA cap processing (Noble et 
al., 2010; Rossi et al., 2012).  
 Four strategies have been pursued to identify 
inhibitors of DENV through targeting both viral and 
host proteins: (i) HTS (high-throughput screening) 
using virus replication assays; (ii) HTS using viral 
enzyme assays; (iii) structure-based in silico docking 
and rational design; (iv) repurposing hepatitis C virus 
inhibitors for DENV (Lim et al., 2013). A number of 
inhibitory agents for the flaviviruses, directed against 
a wide range of both cellular and viral targets have 
already been reported. These include those that 
suppress viral RNA synthesis (Puig-Basagoiti et al., 
2006), inhibitors of NS3 protein helicase and 
protease activities (Knox et al., 2006), suppressors of 
the assembly and maturation of the DENV (Chu and 
Yang, 2007), peptides targeting the E protein (Bai et 
al., 2007), and others that produce interference with 
the structural changes of the envelope protein during 
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viral fusion (Li et al., 2008). However, none of these 
small molecule inhibitors have yet entered clinical 
trials (Kampmann et al., 2009).  
Numerous reports describe antiviral activities 
of plant essential oils on enveloped viruses 
(Duschatzky et al., 2005; Saddi et al., 2007; 
Schnitzler et al., 2008; Koch et al., 2008; Bicchi et 
al., 2009; Wu et al., 2010; Garozzo et al., 2011; Wu 
et al., 2012;). In previous studies we have 
demonstrated inhibitory effects in vitro of the oil 
from Lippia species on DENV (Meneses et al., 
2009a; Meneses et al., 2009b; Ocazionez et al., 
2010). Antiviral properties of essential oils have been 
attributed to their chemical constituents: 
sesquiterpenes and monoterpenes are active on 
enveloped viruses (Armaka et al., 1999; Astani et al., 
2010; Astani et al., 2011).  
To our knowledge, there is no reports about 
the inhibitory effect of essential-oils-derived 
constituents on DENV. In this study, we used in 
silico screening to evaluate the theoretical binding 
affinity of components present in some essential oils 
that have been reported to have inhibitory actions. β-
caryophyllene was subjected to a biological 
examination to assess inhibition in vitro of the 
DENV-2 replication by using cell-based assays. 
 
MATERIALS AND METHODS 
Software 
AutoDock Vina was the primary docking program 
used in this work (Trott & Olson, 2010). The 
geometries of bioactive compounds were obtained 
utilizing Gaussian 03 package (Frisch et al., 2003). A 
molecular format conversion program, Open 
BabelGUI, was used to transform geometries to Mol2 
format for their subsequent processing (O’Boyle et 
al., 2011). The preparation of the pdbqt files and 
determination of the grid box size were carried out 
using Auto-Dock Tools version 1.1. SYBYL 8.1.1 
was utilized to prepare dengue virus protein 
structures (SYBYL, 2007). PyMol (DeLano 
Scientific LLC, USA) was employed to visualize 
protein-ligand complex structures (DeLano, 1998-
2003; Lim et al., 2011). The identification of protein 
residues that interact with the essential oils (EOs) 
components was carried out employing LigandScout 
3.0 (Wolber & Langer, 2005). 
 
Proteins and ligand structure preparation 
The three-dimensional structure of dengue virus 
proteins: capside, premembrane, envelope, 
protease/serine/NTPase, NS5 polimerase and NS5 
methyltransferase were downloaded from Protein 
Data Bank (PDB: 1R6R, 3C5X, 1OAN, 2WHX, 
2J7U and 2P3L, respectively) and prepared with 
SYBYL 8.1.1 package (Maldonado & Olivero, 
2011a). Proteins were minimized using atomic partial 
charges by Kollman method, which describes the 
potential of the system in terms of the energy 
positions of the atoms, and is parameterized for 
proteins and nucleic acids (SYBYL, 2007; Zaheer-ul-
Haq et al., 2010). MGLTools 1.5.0 software was 
utilized to convert structures from PDB to PDBQT 
format, adding polar hydrogens and assigning 
Kollman partial charges (Lauro et al., 2011). Ligands 
chosen to carry out the docking simulation were 
selected based on reports of anti-dengue activity for 
essential oils (Duschatzky et al., 2005; Meneses et 
al., 2009a; Meneses et al., 2009b; Ocazionez et al., 
2010). These molecules (55) were downloaded from 
Pubchem or drawn using Gaussian03 program, saved 
in mol2 format, and optimized by quantum chemical 
calculations, based in Density Functional Theory 
(DFT) at the 6-311G level, using Gaussian 03 as 
previously described (Maldonado et al, 2011b; 
Balachandran et al., 2012). 
 
Protein-ligand docking 
Molecular docking was performed using AutoDock 
Vina. The docking site for ligands on evaluated 
proteins was defined by establishing a cube with a 
sufficient dimension to cover the complete protein, 
with a grid point spacing of 1 Å. One hundred (100) 
runs were carried out by ligand, and for each run the 
best pose was saved. Finally, the average binding 
affinity for best poses was accepted as the binding 
affinity value for a particular complex (Maldonado & 
Olivero, 2011a). The identification of protein 
residues that interact with the essential oils 
components having the greatest affinities was carried 
out with LigandScout 3.0. This program develops 
pharmacophores to propose the number and type of 
primary existing ligand–residue interactions on the 
protein active site (Wolber & Langer, 2005; 
Maldonado & Olivero, 2012). 
 
Docking validation 
The validation of the docking process was carried out 
by redocking with RNA cap site and the S-adenosyl-
L-methionine (SAM) binding site of NS5 MTase 
(2P3L) and the ligands S-adenosyl-L-homocysteine 
(SAH) y ribavirin triphosphate (RVP) into your 
binding site. To examine the broader predictability of 
the docking, we compared the affinity values 
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reported and ours for SAH and RAV. The program of 
identification of protein residues LigandScout 3.0 
was used to do post-docking analyses. Validation of 
the accuracy and performance of AutoDock Vina was 
evaluated by calculating RMSD of the best docked 
conformation of the native ligand and the 
experimental one. 
 
Inhibitory effect of β-Caryophyllene 
Synthetic compounds 
β-Caryophyllene (> 80% purity) was purchased from 
Sigma Aldrich Co. (USA) and it was dissolved in 
solution of 1% DMSO. Ribavirin (Sigma) was 
included as control drug dissolved in test medium. 
 
Cytotoxicity assay 
Cytotoxicity to human cells used for antiviral assays 
was evaluated by the MTT assay as described in a 
previous study (Gómez et al., 2013). Briefly, HepG-2 
cells (from human liver, hepatocellular carcinoma; 
American Type Culture Collection (ATCC) HB-
8065) or HEK-293 cells (from human normal 
embryonic kidney, ATCC CRL-1573) were seeded 
into 96-well plates at 1x10
4
 cells per well and 
incubated for 24 h at 37º C. The medium (DMEM/F-
12) was removed and fresh medium containing 
compound at concentrations of 100, 200, 400, 800 
and 1600 µM was added for 72 h at 37º C. After that, 
medium was removed and MTT solution (20 μL, 5 
mg/mL. Sigma Co.) was added to each well. The 
extent of MTT reduction to formazan was quantified 
by measuring the optical density (OD) at 580 nm. 
Cytotoxicity was expressed as the concentration of 
compound that decreased by 50% (CC50) cell 
viability compared to control (CC50). 
 
Virus yield reduction assay 
A previously described protocol was followed with 
minor modifications (Meneses et al., 2009c). Briefly, 
DENV-2 (local strain G025) was added (31.6 
CCID50/well) onto HepG-2 cells grown in 96-well 
plates. After 1 h, culture medium was removed, the 
cells were washed to remove non-adsorbed virus and 
then incubated in DMEM/F-12 medium containing 
concentrations of compound. At 72 h after 
incubation, the clarified supernatant was collected 
and pooled and stored at -20º C, for later to be tested 
for the presence of DENV-2/NS1 protein using 
PanBio Dengue NS1 Antigen Capture ELISA 
following the manufacture’s instructions. Assays 
were done in duplicate in at least two independent 
experiments, and virus-infected cells in medium 
containing ribavirin or medium free of compound 
were included as controls. The concentration of β-
Caryophyllene that reduced viral NS1 protein 
(PBu.:PanBio units) by 50% (IC50) with respect to 
untreated control was calculated. 
 
Time-of-drug-addition assay 
HepG-2 cells were seeded into 96-well plates at 
1x10
4
 cells per well and incubated for 24 h at 37
o
C. 
The next day, DENV-2 (31.6 CCD50/well) was 
adsorbed for 1 h, the cells were washed to remove 
non-adsorbed virus and then incubated in DMEM/F-
12 medium. β-Caryophyllene (100 µM/well) was 
added to the assay medium at 0 (immediately), 4, 8, 
12 y 24 h after virus adsorption. At 72 h postinfection 
(p.i.) the clarified supernatant was collected to be 
tested for the presence of NS1 protein. To detect 
infectious virus, supernatants were used to infect 
mosquito cells (Aedes albopictus, clone C6/36HT) 
and the presence of DENV-2 was confirmed by 
indirect fluorescent antibody test on virus-infected 
cell as previously described (Ocazionez et al., 2006). 
 
Statistical analysis 
The differences between the means of the variables 
for different groups were evaluated by analysis of 
variance (ANOVA). Results were expressed as mean 
± standard deviation (SD). For all statistical analyzes 
the significance criterion was set at P < 0.05. 
Comparisons between the treated group (β-
caryophyllene) and untreated (control) were 
performed.  
 
RESULTS AND DISCUSSION 
Molecular docking of major compounds of essential 
oils with dengue virus proteins 
AutoDock Vina-calculated affinity scores obtained 
for compounds from EOs on examined dengue virus 
proteins structures (PDB ID: 1R6R, 3C5X, 1OAN, 
2WHX, 2J7U and 2P3L) are presented in Table 1. 
This software was utilized due to its accuracy and 
speed, and is approximately two orders of magnitude 
faster than its predecessor, AutoDock 4 (Trott and 
Olson, 2010). Among the evaluated compounds, (-)-
germacrene D, acting on 2WHX protein, had the 
highest affinity (-7.3 kcal/mol), followed by (-)-α-
copaene, Z-β-caryophyllene, -7.2 and -7.2 kcal/mol 
in the same protein, respectively. These chemicals are 
the major constituents of the EOs of Heterothalamus 
alienus (6.8%), Buddleja cordobensis (8.53%) and B. 
cordobensis (16.54%), respectively, for which 
antiviral activity toward dengue virus has been 
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demonstrated (IC50 122.3 y 86.4 ppm, respectively) 
(Duschatzky et al., 2005; Meneses et al., 2009b). 
However, until now no in silico activity has been 
reported for the individual essential oil component or 
their isomers. 
 The affinity scores for the selected 
components on viral proteins varied between -4.0 and 
-7.3. α-Copaene, germacrene D, β-caryophyllene, 
spathulenol, caryophyllene oxide, β-bourbonene and 
(+)-epi-biciclosesquifellandrene showed the greatest 
theoretical interactions (Figure 2). All of these 
compounds belong to the sesquiterpenes family, and 
they are major constituents of the essential oil from 
B. cordobensis (8.53%), H. alienus (6.8%), Lippia 
citriodora (2.3% - 4.7%), B. cordobensis (32.09% ) 
and Lippia alba (1.7% -8.9%), respectively 
(Duschatzky et al., 2005; Meneses et al., 2009b; 
Ocazionez et al., 2010). Enantiomeric ratios for these 
compounds has not yet been determined. These 
results provide special interest, because it could 
explain the synergistic action of several constituents 
of essential oils, as a requirement to exert their 
antiviral activity. However, experimental studies are 
needed to corroborate this hypothesis. Since β-
caryophyllene showed promising in silico activity, it 
was selected for biological evaluation in order to 
assess its inhibitory effect on DENV-2 replication in 
vitro. 
 
 
 
 
 
 
Figure 2 
Essential oils components with greatest affinities for dengue virus proteins. 1. (-)-α-Copaene. 2. (+)-α-
Copaene. 3. β-Bourbonene. 4. (-)-Germacrene D. 5. (+)-Germacrene D. 6. (+)-Spathulenol. 7. (-)-Spathulenol. 
8. β-Caryophillene. 9. Caryophylene oxide. 10. (+)-Epi-bicyclosesquiphellandrene. 
 
 
 
 
 
Table 1 
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AutoDock Vina-calculated affinities obtained for docking of major components  
of essential oils on DENV proteins 
Componentes de los AEs 
Viral protein / affinity* 
C PrM-E E NS3-NS2B NS5 
1R6R 3C5X 1OAN 2WHX 2J7U 2P3L 
1,8-Cineole -4.3 ± 0.0 -4.9 ± 0.0 -4.4 ± 0.0 -5.9 ± 0.1 -5.1 ± 0.1 -5.1 ± 0.0 
(+)-α-Copaene -5.3 ± 0.0 -5.7 ± 0.1 -5.7 ± 0.1 -6.8 ± 0.0 -6.3 ± 0.0 -6.8 ± 0.0 
(-)-α-Copaene -5.3 ± 0.1 -5.9 ± 0.0 -6.0 ± 0.2 -7.2 ± 0.0 -6.2 ± 0.0 -6.5 ± 0.0 
S-Camphor -4.4 ± 0.0 -5.2 ± 0.1 -4.3 ± 0.0 -6.2 ± 0.0 -5.0 ± 0.0 -5.3 ± 0.0 
D- Camphor -4.4 ± 0.0 -5.1 ± 0.1 -4.3 ± 0.0 -6.1 ± 0.0 -5.1 ± 0.1 -5.1 ± 0.0 
(+)-3-Carene -5.2 ± 0.5 -4.9 ± 0.0 -4.9 ± 0.2 -5.7 ± 0.1 -5.4 ± 0.0 -5.3 ± 0.0 
(-)-3-Carene -5.5 ± 0.8 -4.9 ± 0.0 -5.0 ± 0.0 -5.8 ± 0.1 -5.6 ± 0.0 -5.4 ± 0.0 
3-Octanol -4.3 ± 0.1 -4.1 ± 0.1 -4.0 ± 0.2 -4.5 ± 0.1 -4.3 ± 0.2 -4.5 ± 0.2 
3-Octanone -4.4 ± 0.1 -4.0 ± 0.1 -4.0 ± 0.1 -4.5 ± 0.2 -4.3 ± 0.2 -4.3 ± 0.1 
6-Metil-5-hepten-2-one -4.6 ± 0.1 -4.2 ± 0.1 -4.5 ± 0.1 -4.9 ± 0.1 -4.8 ± 0.2 -4.8 ± 0.0 
α-Pinene -5.3 ± 0.4 -4.9 ± 0.1 -4.6 ± 0.0 -5.8 ± 0.1 -5.0 ± 0.0 -5.0 ± 0.0 
β-Pinene -4.9 ± 0.4 -4.7 ± 0.0 -4.4 ± 0.0 -5.7 ± 0.1 -4.9 ± 0.0 -5.0 ± 0.1 
Artemisia alcohol -4.5 ± 0.2 -4.7 ± 0.1 -4.5 ± 0.0 -5.2 ± 0.2 -4.9 ± 0.2 -5.1 ± 0.0 
β-Bisabolene -5.7 ± 0.2 -5.9 ± 0.2 -5.3 ± 0.2 -6.2 ± 0.2 -5.9 ± 0.1 -6.5 ± 0.2 
β-Bourbonene -5.5 ± 0.1 -6.1 ± 0.0 -5.8 ± 0.2 -7.0 ± 0.0 -6.5 ± 0.0 -6.8 ± 0.0 
Z-β- Caryophillene -5.0 ± 0.0 -5.7 ± 0.1 -5.6 ± 0.0 -7.2 ± 0.0 -6.7 ± 0.0 -6.3 ± 0.0 
E-β- Caryophillene -5.0 ± 0.0 -5.8 ± 0.0 -5.5 ± 0.0 -6.9 ± 0.0 -6.4 ± 0.0 -6.2 ± 0.0 
Caryophylene oxide -5.2 ± 0.0 -6.4 ± 0.4 -5.7 ± 0.0 -7.1 ± 0.0 -6.3 ± 0.1 -6.4 ± 0.0 
β-Mircene -5.0 ± 0.2 -4.2 ± 0.2 -4.8 ± 0.1 -4.7 ± 0.2 -5.0 ± 0.2 -4.8 ± 0.1 
Trans-β-Ocimene -5.0 ± 0.1 -4.6 ± 0.1 -4.8 ± 0.1 -5.1 ± 0.3 -5.1 ± 0.2 -5.2 ± 0.0 
cis-β-Ocimene -4.9 ± 0.1 -4.2 ± 0.1 -4.9 ± 0.2 -5.0 ± 0.3 -5.0 ± 0.2 -4.9 ± 0.1 
β-Sesquiphellandrene -5.6 ± 0.1 -5.3 ± 0.2 -5.7 ± 0.2 -5.9 ± 0.1 -5.8 ± 0.2 -6.3 ± 0.1 
(+)-Epi-Bicyclosesquifellandrene -5.0 ± 0.0 -5.9 ± 0.0 -5.7 ± 0.0 -6.8 ± 0.0 -6.3 ± 0.0 -7.0 ± 0.0 
(+)-Borneol -4.4 ± 0.0 -5.2 ± 0.0 -4.4 ± 0.0 -5.9 ± 0.0 -5.0 ± 0.0 -5.2 ± 0.0 
(-)-Borneol -4.5 ± 0.0 -5.1 ± 0.0 -4.3 ± 0.1 -6.1 ± 0.1 -5.1 ± 0.0 -5.2 ± 0.0 
Carvacril methyl éter -5.3 ± 0.2 -4.9 ± 0.0 -4.9 ± 0.0 -6.1 ± 0.2 -5.9 ± 0.3 -5.7 ± 0.0 
Carvacrol -5.4 ± 0.0 -5.0 ± 0.0 -5.0 ± 0.0 -6.1 ± 0.1 -5.9 ± 0.3 -6.1 ± 0.1 
(+)-Carvone -5.1 ± 0.2 -5.2 ± 0.0 -4.8 ± 0.0 -5.7 ± 0.2 -5.3 ± 0.0 -5.7 ± 0.0 
(-)-Carvone -5.2 ± 0.1 -5.0 ± 0.0 -4.9 ± 0.1 -5.8 ± 0.3 -5.4 ± 0.3 -5.7 ± 0.0 
Chavicol -5.1 ± 0.2 -4.7 ± 0.0 -5.0 ± 0.0 -5.5 ± 0.1 -5.2 ± 0.1 -5.2 ± 0.1 
Geranial -4.6 ± 0.2 -4.5 ± 0.1 -4.8 ± 0.1 -5.2 ± 0.1 -5.1 ± 0.2 -5.4 ± 0.0 
Geraniol -4.5 ± 0.2 -4.5 ± 0.1 -4.9 ± 0.2 -5.3 ± 0.1 -5.1 ± 0.2 -5.6 ± 0.1 
(+)-Limonene -5.3 ± 0.0 -4.9 ± 0.0 -4.7 ± 0.0 -5.5 ± 0.0 -5.5 ± 0.2 -5.4 ± 0.0 
(-)-Limonene -5.3 ± 0.0 -4.9 ± 0.0 -4.8 ± 0.0 -5.6 ± 0.1 -5.6 ± 0.2 -5.3 ± 0.0 
γ-Terpinene -5.5 ± 0.0 -4.8 ± 0.0 -4.7 ± 0.0 -5.5 ± 0.0 -5.6 ± 0.2 -5.5 ± 0.0 
(+)-Piperitone -4.3 ± 0.1 -5.4 ± 0.1 -4.7 ± 0.2 -5.4 ± 0.1 -5.0 ± 0.1 -5.7 ± 0.0 
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(-)-Piperitone -4.6 ± 0.3 -5.4 ± 0.1 -4.9 ± 0.2 -5.8 ± 0.1 -5.4 ± 0.2 -5.5 ± 0.0 
Piperitenone -5.2 ± 0.2 -5.4 ± 0.0 -5.0 ± 0.0 -5.7 ± 0.1 -5.6 ± 0.1 -6.1 ± 0.0 
Estragole -5.1 ± 0.0 -4.7 ± 0.1 -4.7 ± 0.0 -5.4 ± 0.1 -5.4 ± 0.1 -5.3 ± 0.0 
Eugenol -5.1 ± 0.1 -5.1 ± 0.1 -5.2 ± 0.1 -6.1 ± 0.1 -5.4 ± 0.0 -5.5 ± 0.0 
Geranyl acetate -4.9 ± 0.1 -5.0 ± 0.2 -5.0 ± 0.2 -6.0 ± 0.5 -5.4 ± 0.2 -5.6 ± 0.1 
(+)-Germacrene D -5.5 ± 0.4 -5.9 ± 0.0 -5.8 ± 0.1 -6.8 ± 0.2 -6.8 ± 0.0 -6.4 ± 0.0 
(-)-Germacrene D -5.4 ± 0.1 -5.9 ± 0.1 -6.3 ± 0.4 -7.3 ± 0.0 -6.5 ± 0.0 -6.5 ± 0.0 
(+)-Linalool -4.7 ± 0.4 -4.6 ± 0.1 -4.5 ± 0.2 -5.0 ± 0.2 -5.0 ± 0.1 -5.2 ± 0.1 
(-)-Linalool -4.8 ± 0.4 -4.7 ± 0.2 -4.5 ± 0.2 -5.0 ± 0.2 -5.0 ± 0.2 -5.0 ± 0.2 
R-α-Zingiberene -5.8 ± 0.1 -5.8 ± 0.1 -5.3 ± 0.2 -6.2 ± 0.4 -5.8 ± 0.2 -6.4 ± 0.2 
(-)-Spathulenol -5.1 ± 0.0 -6.1 ± 0.0 -5.3 ± 0.1 -6.7 ± 0.0 -6.4 ± 0.1 -6.4 ± 0.0 
(+)-Spathulenol -4.9 ± 0.0 -6.1 ± 0.0 -5.6 ± 0.1 -7.1 ± 0.0 -6.4 ± 0.0 -6.2 ± 0.0 
S-α-Zingiberene -5.9 ± 0.1 -4.8 ± 0.0 -5.1 ± 0.4 -6.0 ± 0.1 -5.7 ± 0.0 -5.8 ± 0.3 
(+)-Trans-Carveol -5.1 ± 0.1 -5.2 ± 0.2 -5.2 ± 0.0 -5.8 ± 0.1 -5.4 ± 0.0 -5.5 ± 0.0 
Neral -4.7 ± 0.2 -4.5 ± 0.1 -4.9 ± 0.2 -5.3 ± 0.2 -5.0 ± 0.2 -5.4 ± 0.1 
Nerol -4.6 ± 0.2 -4.7 ± 0.1 -4.8 ± 0.1 -5.3 ± 0.0 -5.0 ± 0.3 -5.6 ± 0.1 
Sabinene -5.1 ± 0.1 -4.8 ± 0.1 -4.9 ± 0.1 -5.4 ± 0.0 -4.9 ± 0.0 -5.2 ± 0.1 
ρ-Cimeno -5.6 ± 0.0 -4.8 ± 0.0 -4.7 ± 0.1 -5.6 ± 0.1 -5.8 ± 0.1 -5.5 ± 0.0 
*Mean ± SD of affinity (Kcal/mol) for 100 run 
 
Identification of interactions between ligands with 
best in silico affinities and dengue virus proteins 
Interactions between DENV protein and essential oils 
components, as predicted by LigandScout 3.0, are 
shown in Figure 3. Most protein-ligand interactions 
were hydrophobic in nature. More frequently 
interacting residues were VAL, ILE, and THR. In the 
case of the dengue virus protease (2WHX) bound to 
the inhibitor alpinetine, interacting residues with the 
ligand include ILE365A and THR408A, interactions 
were also identify in the (-)-germacrene D-2WHX 
protein complex, which may suggest a possible 
indication of (-)-germacrene D binding to 2WHX. On 
the other hand, important interactions with protein 
NS5 methyltransferase are hydrogen bonds at both 
ends of the elongated SAM molecule, with ASP131 
and VAL132 fixing the adenine moiety and GLY86, 
SER56, and ASP146 fixing the amino acid moiety at 
the opposite end. The elongated binding pocket is 
lined with predominantly apolar residues (Podvinec 
et al., 2010). Other important residues are HIS110, 
LYS105, ASP131 and ILE147, which play an 
important role in the N7 and 2-O'-methylation (Lim 
et al., 2011). The molecule (+)-epi-
bicyclosesquiphellandrene possesses a hydrophobic 
interaction with VAL132 (Figure 3F) and one of the 
residues (ILE147) important in the binding site of 
SAM. These results indicate that this compound can 
block the binding site SAM by interaction with 
critical residues.  
 
Validation of the docking 
Docking validation was performed by redocking co-
crystallized SAH y RVP into their respective binding 
sites. We found that the binding conformations of 
redocked SAH reproduced the binding modes of the 
co-crystallized ligands with binding affinities -7.24 ± 
0.35 kcal/mol and -5.37 ± 0.35 kcal/mol for SAH and 
RVP, respectively (Figure 4). The theoretical binding 
affinity of SAH y RVP reported using Autodock 
Vina were -7.3 and -5.6 kcal/mol, respectely (Lim et 
al., 2011), comparable with the values obtained by 
us. Moreover, the SAM binding pocket is thought to 
be more closed than the RNA cap site. SER56, 
GLY86 and ASP146 interact with the SAH molecule 
by forming hydrogen bonds. In addition, there were 
four hydrophobic interactions between the 
hydrophobic side chains of THR104, LYS105, 
VAL132 and ILE147 in the SAM binding pocket 
with the SAH molecule (Lim et al., 2011). We found 
that LYS105, THR104, GLU111 and GLY86 interact 
with the SAH molecule by forming hydrogen bonds 
and SER56 interact with the SAH molecule by bond 
donor. The RNA cap site of NS5 MTase is an open 
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and shallow pocket. LEU20, ASN18 and LYS29 
forms a hydrogen bond with RVP. A hydrophobic 
interaction between RVP and LEU17 of the RNA cap 
site was observed. The aromatic ring of PHE25 forms 
an aromatic stacking interaction with the pseudobase 
ring of RTP (Lim et al., 2011). We found that 
SER150 and LYS14 interact with the RVP molecule 
by forming hydrogen bonds and ASN18 interact with 
the RVP molecule by bond donor. 
  
 
Figure 3 
3D view and interacting residues present in DENV proteins. A. 1R6R-S-α-zingibelene, B. 3C5X-
Caryophylene oxide, C. 1OAN-(-)-Germacrene D, D. 2WHX -(-)-germacrene D, E. 2J7U-(+)-germacrene D, 
F. 2P3L-(+)-epi-bicyclosesquiphellandrene complexes 
 
There are slight differences between our 
result and the result of Lim et al., 2011 in terms of 
the amino acids that are involved in the interaction 
between SAH and the SAM binding site, and RVP 
and the RNA cap site. We identified one interact 
between SAH and GLU111, which are not identified 
in Lim’s work. However, our results confirm that 
THR104 and GLY86 hydrogen bonds with SAH. 
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Otherwise, we identified two interact between RVP 
and SER150, and LYS14 which are not identified in 
Lim’s work.  
As cited in literature, if the RMSD of the best 
docked conformation of the native ligand is ≤ 2.0 Å 
from the experimental one, the used scoring function 
is successful (Hegazy & Ali, 2012). The RMSD of 
the docked RVP into NS5 MTase was 0.216 Å, and 
that of the docked SAH into NS5 MTase was 0.210 
Å. The obtained success rates of AutoDock Vina 
were highly excellent. 
 
 
Figure 4 
Surface representation of NS5 MTase with SAH and RVP  
in the binding site RNA cap and SAM, respectively. 
 
In vitro antiviral activity of β-Caryophyllene 
To examine whether the cell viability is affected by 
β-caryophyllene, a MTT assay was carried out on 
monolayers of human cells exposed at various 
concentrations of compound for 72 h (Figure 5A). 
For HepG-2, the CC50 was 293.8 ± 62.1 µM (60 ± 
12.7 µg/mL) and the maximum no-toxic 
concentration (MNTC) was 110.5 ± 20.4 µM (22.6 ± 
4.2 µg/mL). For HEK-293, the cell viability was 
reduced by only 48.3% at the highest concentration 
used (1600 µM [327 µg/mL]); therefore, the CC50 
value could not be determined and the MNTC value 
was considered ~ 100 µM. It seems that β-
cariophyllene would be more toxic to cancerous cells 
than normal cells. The classification system of Halle 
and Göres (Halle & Göres, 1987) has defined CC50 
values lower than 50 µM as toxic. In accordance with 
this classification and the MTT results, β-
caryophyllene would be rated as non-toxic for the 
selected human cells. Similar results have been 
reported by others (Soares et al., 2013). 
A virus-NS1 yield reduction assay was next 
employed to study whether β-caryophyllene at non-
toxic concentrations interferes with replication in 
vitro of DENV-2, ribavirin was included as a drug 
reference. In untreated HepG-2 cells, on average 33.5 
± 2.2 PBu. of NS1 were detected. Addition of β-
caryophyllene markedly reduced replication of the 
virus but not in a dose-dependent manner (Figure 
5B). At a concentration of 25 µM (5.1 µg/mL) and 
100 µM (20.4µg/mL), β-caryophyllene inhibited NS1 
by 56.2% and 87.5%, respectively. Relevant antiviral 
activity was confirmed in accordance with the 50% 
inhibitory concentration (IC50) and selectivity index 
(SI = CC50 / IC50): IC50 value of 22.5 ± 5.6 µM (4.6 ± 
1.1 µg/mL) and SI value of 71.1. It has been 
suggested IC50 < 25 µM and SI > 2 as appropriate for 
future applications of pure compounds (Amoros et 
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al., 1992; Cos et al., 2006), thereby, β-caryophyllene 
presents promising antiviral activity against DENV-
2.  
In order to investigate which stage of the 
virus replication cycle could be inhibit, β-
caryophyllene (100 µM) was added to virus-infected 
cells either immediately after virus adsorption or at 
several time points after that. At 72 h p.i., and 
supernatants were collected for quantification of NS1 
and detection of infectious virus (Figure 6). Addition 
of compound at earlier stages p.i. resulted in marked 
reduction of viral replication: at 0 and 4 h, NS1 
reduced 85.1% (5.3 ± 2.6 vs. 35.9 ± 3.4 PBu; p < 
0.05.) and 85.6% (5.2 ± 1.7 vs 35.9 ± 3.4 PBu.; p < 
0.05), respectively. Moreover, virus was not detected 
in C6/36 cells infected with supernatant from 0 h and 
few cells became infected with supernatant from 4 h. 
β-caryophyllene failed to inhibit DENV-2 replication 
when added 8 h after adsorption, concentration of 
NS1 was not markedly different to control (29.8 ± 7.8 
vs. 35.9 ± 3.4 PBu.; p > 0.05) and high proportion of 
C6/36 cells were infected. When the compound was 
added 12 h and 24 h later, there was reduction of NS1 
by, respectively, 85.3% (5.3 ± 2.0 vs. 35.9 ± 3.4 
PBu.; p < 0.05) and 44.1% (20.1 ± 2.8 vs 35.9 ± 3.4 
PBu. p < 0.05).  
 
 
 
Figure 5 
Dose-response curves for β-caryophyllene against DENV-2. Cytotoxicity (A) is expressed as percentage of 
cell growth (viability) with respect to untreated control on HEK-293 cells (▲) and HepG-2 cells (■). 
Antiviral activity (B) was determined by means of a viral protein reduction assay and data are expressed as 
percentage of NS1 PanBio units of untreated virus control. N: untreated. R: treated with ribavirin 
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Figure 6 
Time-of-drug-addition assay. β-caryophyllene (100 µM) was added to DENV-2-infected cells at various time 
points p.i., starting at 0 h (immediately after virus adsorption). At 72 h p.i., the culture supernatant was 
collected to measure NS1 protein (A) or to infect C6/36 cells (B). DENV-2 infection in C6/36 was detected by 
indirect fluorescent antibody test. N: untreated. R: treated with ribavirin. a,b,c,d,e: 0, 4, 8, 12, 24 h p.i. 
 
The precise mechanism of the antiviral action 
of essential oil´s components is still not fully 
understood. In this study, inhibition at 0 h and 4 h but 
not at 8 h provide evidence that β-caryophyllene acts 
preventing virus-cell binding but not intracellular 
events of the DENV cycle. Inhibition at 12 h and 24 
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h, time when viral particles are present in the 
supernantant of HepG-2 infected cells (Thepparit et 
al., 2004), suggests that the compound exerts a 
virucidal action. This is, inactivate DENV masking 
proteins on its envelope that are necessary for 
attachment and/or virus entry into the host cell. In a 
previous study we demonstrated that citral, a mixture 
of terpnenoids present in some essential oils, inhibits 
the replication in vitro of yellow fever virus (from 
flavivirus genus like DENV) before and after 
adsorption to cell (Gómez et al., 2013).  
 
CONCLUSIONS 
This computational study has suggested that all 
DENV proteins are potential targets for simultaneous 
docking of several essential oils’s components. 
Components identified with high affinity in silico for 
DENV proteins were: (-)-α-copaene, (+)-α-copaene, 
β-bourbonene, (-)-germacrene D, (+)-germacrene D, 
(-)-spathulenol, (+)-spathulenol, β-caryophillene, 
caryophillene oxide and (+)-epi-
bicyclosesquiphellandrene. Most components bind to 
their respective binding sites by creating hydrophobic 
interactions with important residues in the binding 
pockets. β-caryophyllene shows promising antiviral 
activity since presents a SI of 71.1 and was active at 
concentration of 22.5 ± 5.6 µM. 
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